• 1. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 2. Evolutionary approaches in protein engineering towards biomaterial construction
  Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734
• 3. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 4. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 5. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzenesulfonamides

Research Brief on N-Cyclohexyl-4-nitrobenzenesulfonamide (CAS: 52374-26-2): Recent Advances and Applications

N-Cyclohexyl-4-nitrobenzenesulfonamide (CAS: 52374-26-2) is a sulfonamide derivative that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its potential applications in drug discovery and development. Recent studies have explored its role as a versatile intermediate in the synthesis of bioactive molecules, as well as its direct pharmacological properties. This research brief aims to summarize the latest findings related to this compound, highlighting its synthetic utility, mechanism of action, and therapeutic potential.

One of the most notable advancements in the study of N-Cyclohexyl-4-nitrobenzenesulfonamide is its application in the design of enzyme inhibitors. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that this compound serves as a key scaffold for the development of selective inhibitors targeting carbonic anhydrase isoforms. The researchers utilized structure-activity relationship (SAR) analysis to optimize the sulfonamide moiety, resulting in derivatives with enhanced binding affinity and isoform specificity. These findings open new avenues for the treatment of diseases such as glaucoma and cancer, where carbonic anhydrase dysregulation plays a critical role.

In addition to its role in enzyme inhibition, N-Cyclohexyl-4-nitrobenzenesulfonamide has been investigated for its antimicrobial properties. A recent Bioorganic & Medicinal Chemistry Letters article reported that this compound exhibits moderate activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). The study proposed that the nitro group and sulfonamide functionality contribute to membrane disruption and interference with bacterial folate metabolism. Further optimization of the compound's structure could lead to the development of novel antibiotics with improved efficacy and reduced resistance.

The synthetic versatility of N-Cyclohexyl-4-nitrobenzenesulfonamide has also been highlighted in recent work. A 2024 Organic & Biomolecular Chemistry paper detailed its use as a building block in multicomponent reactions, enabling the efficient construction of complex heterocyclic frameworks. The researchers emphasized the compound's stability and reactivity under mild conditions, making it an attractive candidate for green chemistry applications. This approach has potential implications for the rapid generation of compound libraries in drug discovery programs.

From a mechanistic perspective, computational studies have provided insights into the molecular interactions of N-Cyclohexyl-4-nitrobenzenesulfonamide with biological targets. Molecular docking simulations published in RSC Advances revealed that the compound adopts a unique binding pose in the active sites of several disease-relevant proteins, facilitated by hydrogen bonding with the sulfonamide group and hydrophobic interactions with the cyclohexyl moiety. These computational predictions align with experimental data and guide the rational design of more potent analogs.

In conclusion, recent research on N-Cyclohexyl-4-nitrobenzenesulfonamide (CAS: 52374-26-2) underscores its multifaceted potential in chemical biology and drug development. Its applications span from enzyme inhibition to antimicrobial activity and synthetic methodology. Future studies should focus on further elucidating its structure-activity relationships, exploring its in vivo efficacy, and expanding its utility in medicinal chemistry. The compound's unique structural features and demonstrated biological activities position it as a promising candidate for continued investigation in the pharmaceutical sciences.

• 477723-14-1(Benzenesulfonamide, N-cyclobutyl-4-nitro-)
• 548789-37-3(N-(6-methylheptan-2-yl)-4-nitrobenzenesulfonamide)
• 912843-59-5(N-(1R,2R)-2-aminocyclohexyl-4-nitrobenzene-1-sulfonamide)
• 424817-23-2(3-nitro-N-(tricyclo[3.3.1.1~3,7~]dec-1-yl)benzenesulfonamide)
• 208394-78-9(4-nitro-N-[1-(tricyclo[3.3.1.1~3,7~]dec-1-yl)ethyl]benzenesulfonamide)
• 349621-62-1(4-nitro-N-(pentan-3-yl)benzenesulfonamide)
• 329941-88-0(N-Cycloheptyl-4-nitrobenzenesulfonamide)
• 93125-79-2(N-Cyclohexyl 3-Nitrobenzenesulfonamide)
• 193904-55-1(Benzenesulfonamide, N-(1R,2R,4S)-bicyclo[2.2.1]hept-2-yl-4-nitro-, rel-)
• 26482-50-8(Benzenesulfonamide, 4-nitro-N-tricyclo[3.3.1.13,7]dec-1-yl-)